The comparison of safety and cost between reference drug of rituximab and its biosimilar Riximyo in lymphoproliferative disorders and other hematological diseases. Single center experience
Article in Leukemia & Lymphoma (October 2023)
The most recent citing publications are shown below. View all 24 publications that cite this research output on Dimensions.
Article in Leukemia & Lymphoma (October 2023)
Preprint in Research Square (September 2023)
Article in Arthritis & Rheumatology (September 2023)